Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Allison Koenig

Adolescent Medicine Atlanta, GA Medical Doctor

NPI 1497751366 CMS profile 339730

105 Collier Rd Nw, Ste 4060, Atlanta, GA 30309

Open in the dashboard

General payments

$3,499

184 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Allison Koenig of Atlanta, GA is reported in the CMS Open Payments database as having received $3,499 across 184 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Adolescent Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $565 27
2024 General $691 32
2023 General $551 27
2022 General $677 38
2021 General $559 32
2020 General $142 7
2019 General $312 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Allison Koenig
  • Adolescent Medicine median
  • Middle half of Adolescent Medicine
  • National median

In program year 2025, general payments to Allison Koenig were reported at $565. Among 914 Adolescent Medicine profiles paid that year, the median was $100 and the middle half received between $40 and $207.

Show as a table
Year Allison Koenig Adolescent Medicine median Middle half National median
2019 $312 $95 $36–$198 $163
2020 $142 $50 $23–$111 $114
2021 $559 $67 $27–$179 $132
2022 $677 $79 $29–$189 $149
2023 $551 $100 $39–$194 $160
2024 $691 $93 $38–$195 $164
2025 $565 $100 $40–$207 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Corium, Inc. $511 21 payments
  2. Tris Pharma Inc $432 23 payments
  3. Pfizer Inc. $277 15 payments
  4. Sanofi-Aventis U.S. LLC $268 12 payments
  5. Supernus Pharmaceuticals, Inc. $263 16 payments
  6. kaleo, Inc. $247 16 payments
  7. Cranial Technologies, Inc $222 11 payments
  8. Ironshore Pharmaceuticals Inc. $200 10 payments
  9. Sanofi Pasteur Inc. $157 9 payments
  10. Neos Therapeutics, LP $102 6 payments
  11. Other $820 45 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,423 182 payments
  2. Gift $48 1 payment
  3. Long term medical supply or device loan $29 1 payment
Products named General payments · program years 2019–2025
  1. Azstarys $511 21 payments
  2. TZIELD $268 12 payments
  3. QELBREE $231 14 payments
  4. Doc Band $222 11 payments
  5. AUVI-Q $205 13 payments
  6. COMIRNATY $205 10 payments
  7. JORNAY PM $137 6 payments
  8. TRUMENBA $129 7 payments
  9. Onyda XR $126 6 payments
  10. VYVANSE $123 7 payments
  11. Other $2,066 120 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

184 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adolescent Medicine in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record